Below All Moving Averages and Now at Lower Circuit: Venus Remedies Ltd Loses 5.0% in a Single Session

Circuit Event and Unfilled Supply

The stock of Venus Remedies Ltd declined by 5.0%, reaching its lower circuit price band of Rs 1,686.8 from a high of Rs 1,768.9 during the session. The 5% price band capped the maximum daily loss, but the exchange floor effectively froze trading at this floor price as sellers overwhelmed demand. This unfilled supply scenario is typical of lower circuit events, especially in micro-cap stocks where liquidity is limited. The persistent queue of sellers with no buyers willing to absorb shares highlights the difficulty in exiting positions at these levels — how deep is the exit problem for Venus Remedies and what would need to change for normal trading to resume?

Delivery and Volume Analysis

Delivery volumes surged sharply to 10,460 shares on 21 Jul, marking a 170.36% increase over the 5-day average delivery volume. On a lower circuit day, rising delivery volume is a significant indicator of genuine selling rather than speculative short-selling. This means holders are liquidating actual positions, not merely intraday traders opening shorts. Total traded volume was 23,257 shares, with a turnover of Rs 3.99 crore, indicating that while the stock is liquid enough for trades around Rs 0.2 crore, much of the supply remained unfilled at the circuit floor. The weighted average price also skewed closer to the low price, reinforcing the dominance of selling pressure throughout the session — does this surge in delivery volume signal capitulation or is further selling pressure likely?

Intraday Price Action

The intraday range spanned from a high of Rs 1,768.9 to the circuit low of Rs 1,686.8, representing a 4.6% swing within the session. The stock opened near the higher end but steadily declined throughout the day, closing at the lower circuit price. This gradual descent rather than a sudden gap-down suggests sustained selling pressure rather than a one-off shock. The weighted average price being closer to the low price further confirms that most trades occurred near the circuit floor, underscoring the lack of buying interest at higher levels.

Moving Averages and Trend Context

Technically, Venus Remedies Ltd trades below its 5-day and 20-day moving averages, signalling short-term weakness. However, it remains above the 50-day, 100-day, and 200-day moving averages, indicating that the longer-term trend has not yet fully broken down. This mixed moving average configuration suggests that the recent selling pressure has accelerated a short-term downtrend but has not yet confirmed a sustained longer-term decline — does the technical profile of Venus Remedies show any nearby support, or is more downside likely?

Liquidity and Exit Risk

With a market capitalisation of Rs 2,329 crore, Venus Remedies Ltd is classified as a micro-cap stock. Despite a turnover of nearly Rs 4 crore on the day, the liquidity profile remains constrained, especially given the unfilled supply at the lower circuit. The stock is liquid enough for trades around Rs 0.2 crore, but any position of meaningful size faces severe exit friction when the price is locked at the circuit floor. This liquidity squeeze can prolong the lower circuit condition, trapping sellers who are unable to exit their holdings — how significant is the liquidity exit risk for Venus Remedies and what implications does this have for sellers?

Fundamental Context

Operating within the Pharmaceuticals & Biotechnology sector, Venus Remedies Ltd has a micro-cap market capitalisation of Rs 2,329 crore. The sector itself underperformed the broader market on the day, with a 1.55% decline compared to the Sensex's 0.81% fall. However, the stock's 5.0% loss and lower circuit lock indicate a stock-specific event rather than a sector-wide sell-off. This divergence highlights the importance of analysing company-specific factors alongside broader market trends.

Conclusion: Severity and Liquidity Caveats

The 5.0% single-day loss culminating in a lower circuit lock for Venus Remedies Ltd reflects a session dominated by genuine selling pressure, as evidenced by the 170% surge in delivery volumes. The stock's position below short-term moving averages confirms the technical weakness, while the micro-cap status and limited liquidity exacerbate exit risks for holders. The unfilled supply at the circuit floor means sellers are effectively trapped, potentially prolonging the downward pressure. After this significant loss, is Venus Remedies approaching oversold territory or does the selling pressure have further to run? The complete analysis weighs the data.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →